You can now submit reviews for your favorite Tocris products. Your review will help other researchers decide on the best products for their research. Why not submit a review today?!Submit Review
PDD 00017238 New
High affinity and potent PARG inhibitor (Kd = 3.09 nM; IC50 = 40 nM).
Negative control PDD 00031705 (Cat. No. 7009) also available.
Sold under license from Cancer Research Technology Ltd (Ximbio).
|Storage||Store at -20°C|
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
|Solvent||Max Conc. mg/mL||Max Conc. mM|
Preparing Stock Solutions
The following data is based on the product molecular weight 476.59. Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
|Concentration / Solvent Volume / Mass||1 mg||5 mg||10 mg|
|0.02 mM||104.91 mL||524.56 mL||1049.12 mL|
|0.1 mM||20.98 mL||104.91 mL||209.82 mL|
|0.2 mM||10.49 mL||52.46 mL||104.91 mL|
|1 mM||2.1 mL||10.49 mL||20.98 mL|
References are publications that support the biological activity of the product.
James et al (2016) First-in-class chemical probes against poly(ADP-ribose) glycohydrolase (PARG) inhibit DNA repair with differential pharmacology to Olaparib. ACS Chem.Biol. 11 3179 PMID: 27689388
If you know of a relevant reference for PDD 00017238, please let us know.
View Related Products by Product Action
Keywords: PDD 00017238, PDD 00017238 supplier, PDD00017238, potent, high, affinity, poly, ADP, ribose, glycohydrolase, PARG, inhibitors, inhibits, Poly(ADP)-ribose, Glycohydrolase, 7007, Tocris Bioscience
Citations for PDD 00017238
Citations are publications that use Tocris products.
Currently there are no citations for PDD 00017238. Do you know of a great paper that uses PDD 00017238 from Tocris? Please let us know.
Reviews for PDD 00017238
There are currently no reviews for this product. Be the first to review PDD 00017238 and earn rewards!
Have you used PDD 00017238?
Submit a review and receive an Amazon gift card.
$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image
$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
Literature in this Area
Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* or download your copy today!
*Please note that Tocris will only send literature to established scientific business / institute addresses.
Epigenetics in Cancer Poster
Adapted from the 2015 Cancer Product Guide Edition 3, this poster summarizes the main epigenetic targets in cancer. The dysregulation of epigenetic modifications has been shown to result in oncogenesis and cancer progression. Unlike genetic mutations, epigenetic alterations are considered to be reversible and thus make promising therapeutic targets.